Abstract:Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that there appeared to be two instances of overlapping data panels comparing between the cell migration and invasion assay data shown in Figs. 4 and 6 on p. 143 and 145, respectively, such that data which were intended to represent the results from differently performed experiments had apparently been derived from the same original sources. In addition, the authors themselves realized that incorrect western blotting data for Snail protein in Fig. 10A on p. 147 had been included in the figure. The authors were able to re‑examine their original data files, and realized that the affected data panels in these figures had inadvertently been incorporated into them incorrectly. The revised versions of Figs. 4, 6, and 10, featuring the correct data for the 'NC / Control' panels in Fig. 4B and C and the 'siRNA2 / ATP 12 h' panels in Fig. 4A and B, a replacement data panel for the 'siRNA1 / Control' experiment in Fig. 6, and the correct western blotting data for Snail protein in Fig. 10A (together with a revised histogram for the MCF7 cell line relating to Fig. 10A) are shown on the next three pages. The authors wish to emphasize that the errors made in compiling these figures did not affect the overall conclusions reported in the paper, and they are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this corrigendum. All the authors agree to the publication of this corrigendum, and also apologize to the readership for any inconvenience caused. [Oncology Reports 39: 138‑150, 2018; DOI: 10.3892/or.2017.6081].

[Corrigendum] The cranberry flavonoids PAC DP‑9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells

[Corrigendum] Crocetin Induces Apoptosis of BGC‑823 Human Gastric Cancer Cells

[Corrigendum] SB‑T‑121205, a Next‑generation Taxane, Enhances Apoptosis and Inhibits Migration/invasion in MCF‑7/PTX Cells.

[Corrigendum] Azurocidin 1 inhibits the aberrant proliferation of triple‐negative breast cancer through the regulation of pyroptosis

[Corrigendum] METTL3 Antagonizes 5‑FU Chemotherapy and Confers Drug Resistance in Colorectal Carcinoma.

[Corrigendum] The role of IGFBP‑5 in mediating the anti‑proliferation effect of tetrandrine in human colon cancer cells

[Retracted] Sulforaphane regulates apoptosis‐ and proliferation‐related signaling pathways and synergizes with cisplatin to suppress human ovarian cancer

[Corrigendum] P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT‑related genes Snail and E‑cadherin

[Corrigendum] Tripartite motif‐containing 11 regulates the proliferation and apoptosis of breast cancer cells

[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer

[Corrigendum] Effect of STC2 gene silencing on colorectal cancer cells

[Corrigendum] ANXA1‑derived Peptides Suppress Gastric and Colon Cancer Cell Growth by Targeting EphA2 Degradation

[Corrigendum] Resveratrol reverses P‐glycoprotein‐mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF‐κB and p38 MAPK signaling pathways

Correction: Cepharanthine Hydrochloride Reverses the Mdr1 (P-Glycoprotein)-mediated Esophageal Squamous Cell Carcinoma Cell Cisplatin Resistance Through JNK and P53 Signals

[Corrigendum] Jak3 is involved in CCR7‐dependent migration and invasion in metastatic squamous cell carcinoma of the head and neck

[Corrigendum] High PLK4 Expression Promotes Tumor Progression and Induces Epithelial‑mesenchymal Transition by Regulating the Wnt/β‑catenin Signaling Pathway in Colorectal Cancer

[Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‐4 in vitro and in vivo

[Retracted] Mir‑218 Suppresses Tumor Growth and Enhances the Chemosensitivity of Esophageal Squamous Cell Carcinoma to Cisplatin

[Corrigendum] Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.

[Corrigendum] Hispolon inhibits breast cancer cell migration by reversal of epithelial‑to‑mesenchymal transition via suppressing the ROS/ERK/Slug/E‑cadherin pathway.

[Corrigendum] Effects of miR‑340 overexpression and knockdown on the proliferation and metastasis of NSCLC cell lines